CannaVest Reports Second Quarter 2014 Financial Results
LAS VEGAS, Aug. 14, 2014
LAS VEGAS, Aug. 14, 2014 /PRNewswire/ --CannaVest Corp. - ("CannaVest" or the
"Company") is reporting financial results for the quarter ending June 30,
During the quarter, CannaVest continued investing in its San Diego
headquarters and laboratory facilities expansion, and in its sales, marketing,
and finance personnel additions; and it completed a major milestone in
establishing a domestic industrial hemp cultivation infrastructure, via its
involvement in one of the first U.S. pilot cultivations of industrial hemp.
"We continue to expand our infrastructure investment, both internally, and
now, in the field," said Michael Mona, President and Chief Executive Officer
of CannaVest. "By making investments in key personnel and operating
infrastructure, and now, with our historic involvement in the first legal
cultivation pilot at Kentucky'sMurray State University since the passage of
the 2014 Farm Bill- we are positioned to establish industrial hemp as a vital
Second Quarter 2014 Operating Results
The Company's net income for the second quarter of 2014 was $8,040,430, or
$0.24 per share (basic and diluted), compared to a net loss of $348,134, or
$0.04 per share (basic and diluted) for the same period in 2013.
Net income for the second quarter 2014 included $7,899,306 of gain on sale of
the Company's equity investment in KannaLife Sciences, Inc. ("KannaLife"). The
Company sold its 24.97% equity investment in KannaLife for 500,000 shares of
Company common stock held by PhytoSPHERE Systems, LLC, an affiliate of
KannaLife. There was no cash exchanged in the transaction. Net income from
operations was $131,892 for the quarter ended June 30, 2014, compared to an
operating loss of $327,611 for the same period in 2013.
Selling, general and administrative expenses for the second quarter of 2014
were $1,507,423 compared to $419,002 for the same period in 2013. The increase
was related to the continued growth of the operations of the Company,
technology infrastructure investments, and increased legal and marketing
Research and development costs for the second quarter of 2014 were $156,501.
This includes the cost of process development, rental of laboratory space,
personnel costs, laboratory supplies, product development and testing.
Balance Sheet Highlights
As of June 30, 2014, the Company had cash of approximately $9.3 million.
Stockholders equity amounted to approximately $22.4 million as of June 30,
For a further discussion of the Company's financial results for the period
ended June 30, 2014, please refer to the Company's consolidated financial
statements and related Management Discussion and Analysis, which can be found
at www.CannaVest.com or EDGAR at www.sec.gov/edgar/searchedgar/webusers.htm in
the Company's Quarterly Report on Form 10-Q as filed with the U.S. Securities
and Exchange Commission on August 14, 2014.
About CannaVest Corp.
CannaVest Corp. (OTCBB: CANV), located in Las Vegas, Nevada, focuses on the
procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the
development, marketing and sale of end consumer products containing CBD, which
is refined into its own PlusCBD Oil™ brand. CannaVest resells raw industrial
hemp product to third parties, acquired through supply relationships in
Europe. Additional information is available from OTCMarkets.com or by visiting
CannaVest Corp.'s subsidiaries include: US Hemp Oil, LLC ("US Hemp Oil") (
http://www.USHempOil.com ), CannaVest Laboratories, LLC ("CannaVest
Laboratories") ( http://www.CannaVestLabs.com ) and Plus CBD, LLC (formerly,
Global Hemp Source, LLC) ("Plus CBD"). US Hemp Oil provides farming,
procurement, processing, marketing and distribution services of bulk wholesale
hemp seed. In addition, US Hemp Oil is involved with industry advocacy,
creating greater public awareness and media exposure for the nutritional
profile of hemp seeds and the environmental benefits of growing industrial
hemp. CannaVest Laboratories (formerly PhytoSPHERE Systems, LLC) provides
processing technology and product development of hemp-based pharmaceutical and
nutraceutical products. Plus CBD is the operating entity for Company sales and
expense of CBD oil and end consumer products.
This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended, and is subject to the Safe Harbor created by those sections.
This material contains statements about expected future events and/or
financial results that are forward-looking in nature and subject to risks and
uncertainties. Such forward-looking statements by definition involve risks,
uncertainties and other factors, which may cause the actual results,
performance or achievements of CannaVest Corp. to be materially different from
the statements made herein.
CannaVest Corp. does not sell or distribute any products that are in violation
of the United States Controlled Substances Act (US.CSA). The company does
grow, sell and distribute hemp-based products and are involved with the
federally legal distribution of medical marijuana-based products within
certain international markets.
Corporate Contact: CannaVest Corp. 2688 S. Rainbow Blvd., Ste. B Las Vegas, NV
89146 Office: 866-290-2157
Press spacebar to pause and continue. Press esc to stop.